Director, Global Commercial, Cell Therapy, Multiple Myeloma

Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us .

Summary : The Global Commercial Multiple Myeloma Director is responsible, for (1) setting the strategic vision and strategy for our MM CAR T business, including Go-to-Market and launch strategy/readiness activities for LCM opportunities for arlo-cel (first-in-class GPRC5D CAR T), and (2) providing Commercial strategy and planning for new MM assets entering late stage development.    This individual will bring strong commercial instincts, a deep understanding of multiple myeloma, and the ability to synthesize complex, cross-functional and regional inputs into clear strategic recommendations. They will work closely with the matrix team to ensure globally aligned, locally relevant execution. The role will report to the VP, Global Commercial, Cell Therapy, Hematology with a dotted line to the ED, Global Commercial, Cell Therapy, Multiple Myeloma.  Key Responsibilities : Drive development and execution of the strategic brand plan, GTM strategy, and global launch plan for arlo-cel (first-in-class GPRC5D CART) lifecycle opportunities Foster a collaborative, insight-driven culture of continuous learning across the global commercial community  Ownership of arlo-cel LCM activities in partnership with the rest of the MM brand team, including: Accountable for WW Commercial launch readiness Lead commercial opportunity assessments and geographic footprint expansion, integrating market insights, competitive intelligence, and pricing dynamics to formulate clear strategic options and recommendations  Translate market insights and performance data into strategic trade-offs and actionable recommendations for senior leadership and governance forums  Align with Commercial teams across Hematology to ensure integrated strategy and execution Interface with functions (e.g., GDD, Commercial, CTDO) to synthesize inputs into a cohesive cross-functional franchise-level MM CT brand plan Lead strategy development for new MM assets entering late development Lead commercial planning and execution excellence, including development of key enablement materials (campaign frameworks, messaging, competitive tools), oversight of agency management and budgets, and prioritization of congress presence and scientific engagement in partnership with cross-functional stakeholders  Partner closely with the Global Executive Director to shape strategic recommendations and support key governance decisions on high-impact topics (e.g., indication expansion, market and site activation, timing delays, slot allocation)  Serve as the primary global commercial partner to selected markets, ensuring strong alignment with global strategy while enabling locally relevant execution and accelerating performance through best practice sharing and cross-market insights  Serve as the lead with support from the Multiple Myeloma Cell Therapy Lead for arlo-cel LCM/new asset positioning/corporate message development and IR messaging, pressure-testing messaging Act as a central point of coordination for patient advocacy and broader stakeholder engagement